As technology advances and markets globalize, and with increasing demands from consumers for the safety and quality of medicinal products, Taiwan has fully implemented the international PIC/S GMP standards to ensure the quality of medicinal products. For foreign pharmaceutical manufacturers exporting medicinal products to Taiwan, the Taiwan Food and Drug Administration (TFDA) dispatches inspectors to conduct on-site inspections or review documents to verify their compliance with GMP standards. Additionally, as a Participating Authority of the Pharmaceutical Inspection Co-operation Scheme (PIC/S), TFDA can share information with other members. This includes sharing information on quality defects of medicinal products or non-compliance with GMP through the PIC/S Rapid Alert and Recall System. This enables immediate assessment of the impact and allows for prompt measures to address any potential risks.